fully agree @slick that positions are being taking to compensate booked exposure. join me for a minute though as i remove myself from reality - which happens often i am told, and disassociate from a mainstream bias which assume all hedges are short and signals of adversity in motion. is it possible that what if we are witnessing is a situation where the historically more dominate short hedges are exiting the market and being replaced by the lesser dominate by volume long hedges? imo this could this go a way to explain the minimal volatility and slow and steady decline over the last 3 months. imo this could go a way to explain some of the action that takes place during the auction period. is it possible that we are experiencing is the transitional stage of a development company as it moves away from a speculative investment to a more liquid asset? just a theory from someone who likes to investigate subtle tells and outliers in data streams. purely me hypothesising. could be wrong though. often am.
IMU
imugene limited
Add to My Watchlist
18.2%
!
1.3¢

IMUGENE CHART. TA only, page-30866
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3258567 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5735292 | 0.012 |
35 | 10497532 | 0.011 |
118 | 35980571 | 0.010 |
37 | 19431668 | 0.009 |
13 | 4220748 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3078567 | 8 |
0.014 | 10063029 | 39 |
0.015 | 6593187 | 20 |
0.016 | 6224494 | 27 |
0.017 | 7006978 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online